Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong
· Delayed Price · Currency is HKD 2.760
+0.050 (1.85%)
Apr 29, 2026, 4:08 PM HKT
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Company Description
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd., engages in the research, development, manufacture, and sale of biopharmaceutical products in the People's Republic of China.
It offers photodynamic technology drugs, such as aminolevulinic acid hydrochloride and hemoporfin for Injection; doxorubicin liposome under the Libord brand; genetic engineering drugs; and oral solid preparation technology drugs.
The company was founded in 1996 and is based in Shanghai, the People's Republic of China.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.
| Country | China |
| Founded | 1996 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 876 |
| CEO | Da Jun Zhao |
Contact Details
Address: Zhangjiang Hi-Tech Park Shanghai, 201210 China | |
| Phone | 86 21 5895 3355 |
| Website | fd-zj.com |
Stock Details
| Ticker Symbol | 1349 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000000W4 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Da Jun Zhao | Co-Founder, GM and Executive Chairman |
| Jun Li | Co-Founder and Deputy GM |
| Xue Yan ACCA, CIA, CICPA, FCCA, HKICPA | Chief Financial Officer, Deputy GM, Company Secretary and Executive Director |
| Dai Qing Yu | Deputy General Manager |
| Yu Chen | Deputy General Manager |
| Lei Qin | Deputy General Manager |
| Wen Zhang | Accounting Supervisor |
| Luo Chun Wang | Core Technical Personnel |
| Xiaowen Li | Deputy General Manager |
| Jian Ping Jiang | Core Technical Personnel |